Article
Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.
Neuropeptides - 1 Dec 2012
Aghili Nima, Devaney Joseph M, Alderman Lee O, Zukowska Zofia, Epstein Stephen E, Burnett Mary Susan
Abstract excerpt
BACKGROUND: Dipeptidyl peptidase IV (DPP-IV) is not only important in pancreatic β-cell regulation but also has proinflammatory actions that can contribute to atherosclerosis progression. Previously, we showed that DPP-IV is co-localized with CD31 (an endothelial cell marker) in the neovessels within the human atherosclerotic plaques. These characteristics of DPP-IV may predispose patients with coronary artery...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
